Tackling an Expensive Problem in Healthcare Delivery
OtoNexus Medical Technologies aspires to revolutionize the management of middle ear infections (otitis media), promoting a more accurate, efficient, and patient-centered approach to detection and treatment. The treatment and management of otitis media results in over $5 billion annually in U.S. healthcare expenditures. By developing a simple-to-use tool that can be integrated seamlessly into the current clinical workflow, OtoNexus aims to improve diagnostic accuracy to lead to the reduced need for antibiotic therapy, surgical interventions and fewer complications.
Company Goals
Developing a Precision Diagnostic Tool: Creating an innovative medical device that enables healthcare professionals to accurately determine the presence and type of middle ear infection (bacterial vs. viral infected effusion). This tool aims to empower clinicians with the confidence to make informed decisions regarding the appropriate course of treatment.
Promoting Efficient Healthcare Delivery: Implementing a data-driven solution to alleviate the current strain on healthcare resources regarding the management of middle ear infections.
Ensuring Patient Safety and Well-being: Providing a reliable basis for medical practitioners to recommend antibacterial therapy or surgical treatment only when necessary. This initiative aims to reassure parents and patients of the judicious use of medical interventions, thereby mitigating the risk of adverse effects, such as antibiotic resistance and permanent hearing loss.
Supporting Public Health Guidelines: Offering a technological solution that aligns with the American Academy of Pediatrics guidelines on the prudent prescription of antibiotics for middle ear infections. The ultrasound otoscope will serve as a critical instrument in limiting antibiotic usage to unequivocally justified cases, thereby contributing to a broader public health objective of antibiotic stewardship.
Four major stakeholder groups may benefit from the OtoNexus ultrasound otoscope solution for middle ear infection detection. The potential benefits of each group's adoption are outlined below.
Parents and Patients
• Receive timely, accurate diagnosis and treatment
• Reduce visits, infections, and surgeries
• Reduce instances of permanent hearing loss
• Reduce stress and anxiety since test results are communicated and understood
Clinicians
• Instantly determine the type of middle ear effusion present
• New tool to identify asymptomatic middle ear infection
• Usable by all levels of caregivers - physicians, nurse practitioners, physician assistants
Insurance Companies
• Accurate diagnosis by the first caregiver the child sees
• Significantly reduce insurer’s middle ear infection cost
• Drive care down to the least-cost provider while increasing accuracy
Hospitals and Medical Societies
• Driving the reduction of antibiotics to address the global problem of antibiotic resistance
• Guidelines provide a transparent treatment approach, but current tools are inadequate to differentiate
Join us in our mission to improve the accurate detection of middle ear infections. To learn more about our company, please complete the form below to contact us.